article

1. Clin-STAR Corner: Practice Changing Advances at the Interface of Oncology and Geriatrics..  Journal of the American Geriatrics Society.  73:2012-2018. 2024
2. Circulating Tumor DNA Testing in Curatively Resected Colorectal Cancer and Salvage Resection..  JAMA network open.  7:-. 2024
3. The role of negative hyperselection in metastatic colorectal cancer..  Journal of gastrointestinal oncology.  15:2353-2357. 2024
4. Palbociclib in adults aged 70 years and older with advanced breast cancer: A phase 2 multicenter trial (Alliance A171601)..  Journal of geriatric oncology.  15:-. 2024
5. Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: results from the Hurria Older PatiEnts (HOPE) prospective study..  Journal of cancer survivorship : research and practice.  18:1131-1143. 2024
6. Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial..  Cancer.  130:936-946. 2023
7. Toxicity Risk Score and Clinical Decline After Adjuvant Chemotherapy in Older Breast Cancer Survivors..  Journal of the National Cancer Institute.  115:578-585. 2023
8. EGFR.  JTO clinical and research reports.  4:-. 2023
9. Low-Intensity Adjuvant Chemotherapy for Breast Cancer in Older Women: Results From the Prospective Multicenter HOPE Trial..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  41:316-326. 2022
10. Clinical Trial Enrollment, Ineligibility, and Reasons for Decline in Older vs Younger Patients With Cancer in the National Cancer Institute Community Oncology Research Program..  JAMA network open.  5:-. 2022
11. Inflammation and Clinical Decline After Adjuvant Chemotherapy in Older Adults With Breast Cancer: Results From the Hurria Older Patients Prospective Study..  Journal of clinical oncology : official journal of the American Society of Clinical Oncology.  41:307-315. 2022
12. Resilience in older adults with cancer: A scoping literature review..  Journal of geriatric oncology.  14:-. 2022
13. KRAS.  OncoTargets and therapy.  747-756. 2022
14. Early Alectinib Resistance From MET Amplification in ALK-Rearranged NSCLC: Response to Crizotinib with Re-Response to Alectinib and Crizotinib..  Clinical lung cancer.  22:e851-e855. 2021
15. Development and Validation of Sorafenib-eluting Microspheres to Enhance Therapeutic Efficacy of Transcatheter Arterial Chemoembolization in a Rat Model of Hepatocellular Carcinoma..  Radiology. Imaging cancer.  3:-. 2021
16. Wild-type APC Is Associated with Poor Survival in Metastatic Microsatellite Stable Colorectal Cancer..  The oncologist.  26:208-214. 2020
17. Variability in multimodality treatment influences survival in non-metastatic gastric cancer patients..  Journal of gastrointestinal oncology.  11:952-963. 2020
18. Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case Series..  Journal of the National Comprehensive Cancer Network : JNCCN.  18:798-804. 2020
19. Recent Advances in Targeted Therapies for Advanced Gastrointestinal Malignancies..  Cancers.  12. 2020
20. The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case Report..  Frontiers in oncology.  -. 2020
21. Iron-Oxide Nanocluster Labeling of Clostridium novyi-NT Spores for MR Imaging-Monitored Locoregional Delivery to Liver Tumors in Rat and Rabbit Models..  Journal of vascular and interventional radiology : JVIR.  30:1106-1115.e1. 2019
22. miR-9a minimizes the phenotypic impact of genomic diversity by buffering a transcription factor..  Cell.  155:1556-67. 2013